Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. (Record no. 20977250)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02261 a2200649 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516044314.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201110s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1474-5488 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S1470-2045(11)70150-4 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Coiffier, Bertrand |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20111005 |
| 245 00 - TITLE STATEMENT | |
| Title | Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Oncology |
| Date of publication, distribution, etc. | Aug 2011 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 773-84 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Murine-Derived |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Boronic Acids |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Bortezomib |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Infusion Pumps |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphoma, Follicular |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Staging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrazines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Recurrence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rituximab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Osmanov, Evgenii A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hong, Xiaonan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Scheliga, Adriana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mayer, Jiri |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Offner, Fritz |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rule, Simon |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Teixeira, Adriana |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Walewski, Jan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | de Vos, Sven |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Crump, Michael |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shpilberg, Ofer |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Esseltine, Dixie-Lee |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhu, Eugene |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Enny, Christopher |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Theocharous, Panteli |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van de Velde, Helgi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Elsayed, Yusri A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zinzani, Pier Luigi |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Oncology |
| Related parts | vol. 12 |
| -- | no. 8 |
| -- | p. 773-84 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1470-2045(11)70150-4">https://doi.org/10.1016/S1470-2045(11)70150-4</a> |
| Public note | Available from publisher's website |
No items available.